+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11



Polymorphism of transporter associated with antigen presentation 1 as a potential determinant for severity of disease in recurrent respiratory papillomatosis caused by human papillomavirus types 6 and 11



Journal of Infectious Diseases 189(5): 871-879



Recurrent respiratory papillomatosis (RRP) is a rare disease caused by human papillomaviruses (HPVs). It is characterized by multiple recurrences of benign neoplasms and has a variable clinical course, ranging from infrequent recurrence to acute airway obstruction. One way in which HPV subverts the immune system in RRP is by interfering with TAP1 (transporter associated with antigen presentation 1). We examined whether a known TAP1 polymorphism in the ATPase domain altered the severity of disease in patients with RRP. The presence of this polymorphism was significantly correlated with severity of disease (P=.015). Because of the proximity of the TAP1 gene to human leukocyte antigen (HLA) class II genes on chromosome 6, we postulated that a linkage disequilibrium may exist. Of the patients with polymorphic TAP1, 36% were positive for HLA-DRB1*0102 (P=.021; P=.147 with Bonferroni's correction). However, this association appeared to mitigate the severity of disease (P=.04). Therefore, severity of disease in a patient with RRP might be determined by sequencing TAP1, in conjunction with HLA class II genes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012427786

Download citation: RISBibTeXText

PMID: 14976605

DOI: 10.1086/381764


Related references

Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis. Archives of Otolaryngology--Head & Neck Surgery 126(9): 1119-1123, 2000

Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. Pediatric Infectious Disease Journal 27(2): 149-154, 2008

Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology 83(): 94-98, 2016

Nucleotide and phylogenetic analysis of human papillomavirus types 6 and 11 isolated from recurrent respiratory papillomatosis in Brazil. Infection, Genetics and Evolution 16: 282-289, 2014

Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatric and Developmental Pathology 4(1): 68-72, 2001

The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination. Vaccine 26(35): 4513-4518, 2008

Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis. Journal of the Medical Association of Thailand 97 Suppl 6(): S136-S141, 2015

Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 114(11 Pt 2 Suppl 104): 1-23, 2004

Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. Head & Neck 37(11): 1625-1632, 2016

Detection of human papillomavirus in the upper respiratory tract in children without recurrent respiratory papillomatosis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 47(12): 974-977, 2014

Prevalence of human papilloma virus types and their influence on the course of the disease in children suffering from recurrent respiratory papillomatosis. Vestnik Otorinolaringologii: 29-33, 2004

Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. Annals of Otology, Rhinology, and Laryngology 101(5): 408-412, 1992

Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. Archives of Otolaryngology--Head & Neck Surgery 119(5): 554-557, 1993

Human papillomavirus infection in recurrent upper respiratory tract papillomatosis. Archiv fuer Geschwulstforschung 60(6): 429-434, 1990

The heterogeneous distribution of human papillomavirus activities in recurrent respiratory papillomatosis. Journal of Investigative Medicine 43(SUPPL 1): 1A, 1995